224 related articles for article (PubMed ID: 31056671)
1. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
[TBL] [Abstract][Full Text] [Related]
2. De novo GABRG2 mutations associated with epileptic encephalopathies.
Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
[TBL] [Abstract][Full Text] [Related]
3. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
[TBL] [Abstract][Full Text] [Related]
4. De novo GABRA1 mutations in Ohtahara and West syndromes.
Kodera H; Ohba C; Kato M; Maeda T; Araki K; Tajima D; Matsuo M; Hino-Fukuyo N; Kohashi K; Ishiyama A; Takeshita S; Motoi H; Kitamura T; Kikuchi A; Tsurusaki Y; Nakashima M; Miyake N; Sasaki M; Kure S; Haginoya K; Saitsu H; Matsumoto N
Epilepsia; 2016 Apr; 57(4):566-73. PubMed ID: 26918889
[TBL] [Abstract][Full Text] [Related]
5. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
[TBL] [Abstract][Full Text] [Related]
6. A case of GABRA5-related developmental and epileptic encephalopathy with response to a combination of antiepileptic drugs and a GABAering agent.
Boonsimma P; Suwannachote S; Phokaew C; Ittiwut C; Suphapeetiporn K; Shotelersuk V
Brain Dev; 2020 Aug; 42(7):546-550. PubMed ID: 32249079
[TBL] [Abstract][Full Text] [Related]
7. A structural look at GABA
Hernandez CC; Macdonald RL
Brain Res; 2019 Jul; 1714():234-247. PubMed ID: 30851244
[TBL] [Abstract][Full Text] [Related]
8. A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro.
Steudle F; Rehman S; Bampali K; Simeone X; Rona Z; Hauser E; Schmidt WM; Scholze P; Ernst M
Sci Rep; 2020 Feb; 10(1):2379. PubMed ID: 32047208
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy.
Bai YF; Chiu M; Chan ES; Axerio-Cilies P; Lu J; Huh L; Connolly MB; Guella I; Farrer MJ; Xu ZD; Liu L; Demos M; Wang YT
Mol Brain; 2019 Nov; 12(1):92. PubMed ID: 31707987
[TBL] [Abstract][Full Text] [Related]
10. Functional genomics of epilepsy-associated mutations in the GABA
Absalom NL; Ahring PK; Liao VW; Balle T; Jiang T; Anderson LL; Arnold JC; McGregor IS; Bowen MT; Chebib M
J Biol Chem; 2019 Apr; 294(15):6157-6171. PubMed ID: 30728247
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.
Johannesen K; Marini C; Pfeffer S; Møller RS; Dorn T; Niturad CE; Gardella E; Weber Y; Søndergård M; Hjalgrim H; Nikanorova M; Becker F; Larsen LH; Dahl HA; Maier O; Mei D; Biskup S; Klein KM; Reif PS; Rosenow F; Elias AF; Hudson C; Helbig KL; Schubert-Bast S; Scordo MR; Craiu D; Djémié T; Hoffman-Zacharska D; Caglayan H; Helbig I; Serratosa J; Striano P; De Jonghe P; Weckhuysen S; Suls A; Muru K; Talvik I; Talvik T; Muhle H; Borggraefe I; Rost I; Guerrini R; Lerche H; Lemke JR; Rubboli G; Maljevic S
Neurology; 2016 Sep; 87(11):1140-51. PubMed ID: 27521439
[TBL] [Abstract][Full Text] [Related]
12. Dravet syndrome-associated mutations in
Hernandez CC; Tian X; Hu N; Shen W; Catron MA; Yang Y; Chen J; Jiang Y; Zhang Y; Macdonald RL
Brain Commun; 2021; 3(2):fcab033. PubMed ID: 34095830
[TBL] [Abstract][Full Text] [Related]
13. Differential Coassembly of α1-GABA
Hannan S; Affandi AHB; Minere M; Jones C; Goh P; Warnes G; Popp B; Trollmann R; Nizetic D; Smart TG
J Neurosci; 2020 Jul; 40(29):5518-5530. PubMed ID: 32513829
[TBL] [Abstract][Full Text] [Related]
14. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
[TBL] [Abstract][Full Text] [Related]
15. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
[TBL] [Abstract][Full Text] [Related]
16. A novel variant in GABRB2 associated with intellectual disability and epilepsy.
Srivastava S; Cohen J; Pevsner J; Aradhya S; McKnight D; Butler E; Johnston M; Fatemi A
Am J Med Genet A; 2014 Nov; 164A(11):2914-21. PubMed ID: 25124326
[TBL] [Abstract][Full Text] [Related]
17. Rare variants in the GABA
Markus F; Angelini C; Trimouille A; Rudolf G; Lesca G; Goizet C; Lasseaux E; Arveiler B; van Slegtenhorst M; Brooks AS; Abou Jamra R; Korenke GC; Neidhardt J; Owczarek-Lipska M
Mol Genet Genomic Med; 2020 Sep; 8(9):e1388. PubMed ID: 32588540
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
Kang JQ; Macdonald RL
JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
[TBL] [Abstract][Full Text] [Related]
19. Altered Channel Conductance States and Gating of GABA
Hernandez CC; Kong W; Hu N; Zhang Y; Shen W; Jackson L; Liu X; Jiang Y; Macdonald RL
eNeuro; 2017; 4(1):. PubMed ID: 28197552
[TBL] [Abstract][Full Text] [Related]
20. Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.
Hernandez CC; Klassen TL; Jackson LG; Gurba K; Hu N; Noebels JL; Macdonald RL
PLoS One; 2016; 11(9):e0162883. PubMed ID: 27622563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
